To evaluate cancer-specificity, the promoter methylation levels of RASSF1A, DAPK1, SOX1, HOXA9, HIC1, SPARC, and SFRP1 were quantitatively analyzed by MethyLight in singleplex and multiplex assays. The gene discussed is SPARC; the disease is cancer.